CW April 2004
Volume 13Issue Number 4 April 2004 ISSN 10593802 Phase III Trial of XYOTAX for Ovarian CancerA phase III trial is planned to investigate the efficacy of a novel polymer to deliver anticancer drugs to an ovarian tumor.
Go to Previous Page Go to Next Page Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
